Pulmonary & Nasal Delivery

Issue No #37  November 1st, 2012

Download PDF

How Nasal Delivery Can Meet the Changing Needs of Patients & the Drug Development Industry
Dr Shunji Haruta, Executive Officer
Mr Jean-Marc Pardonge, President
Aptar Pharma Prescription Division
Dry Nasal Powders: a New Analytical Challenge?
Dr Paul Kippax, Product Group Manager
Malvern Instruments
What’s in a GSD?
Dr Bob Lott, Founder
CI Informatics
Single-Dose Inhalers for Capsules: a Consolidated Tradition with Ample Growth Prospects
Mr Pierluigi Magni, Group Marketing Manager
Conference Report
39th Annual Meeting & Exposition of the Controlled Release Society 2012
Inhalation Manufacturing: Cold Fill, Pressure Fill, and Finding the Right Partner
Ross Errington, Business Development Manager
3M Drug Delivery Systems
Conference Report
Respiratory Drug Delivery (RDD) 2012
Recombinant Human Albumin: Delivering the Future of Type 2 Diabetes Medication
Dr Mark Perkins, Customer Solution Specialist
Novozymes Biopharma US